Tanja E Argillander1, Jan J Koornstra2, Mariette van Kouwen3, Alexandra Mj Langers1, Fokko M Nagengast3, Juda Vecht4, Wouter H de Vos Tot Nederveen Cappel4, Evelien Dekker5, Peter van Duijvendijk6, Hans Fa Vasen1. 1. Department of Gastroenterology & Hepatology, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Gastroenterology & Hepatology, University Medical Center Groningen, Groningen, The Netherlands. 3. Department of Gastroenterology & Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Department of Gastroenterology & Hepatology, Isala Clinics, Zwolle, The Netherlands. 5. Department of Gastroenterology & Hepatology, Academic Medical Center, Amsterdam, The Netherlands. 6. Department of Surgery, Gelre Hospitals, Apeldoorn, The Netherlands.
Abstract
BACKGROUND AND OBJECTIVE: Despite intensive colonoscopic surveillance, a substantial proportion of Lynch syndrome (LS) patients develop colorectal cancer (CRC). The aim of this study was to characterize incident CRC in LS patients. METHODS: All patients diagnosed with incident CRC after start of colonoscopic surveillance were identified in the Dutch LS Registry of 905 patients. A retrospective analysis of patient records was carried out for patient characteristics, survival, CRC characteristics and findings of previous colonoscopy. RESULTS: Seventy-one patients (7.8%) were diagnosed with incident CRC. Median interval between incident CRC diagnosis and previous colonoscopy was 23.8 (range 6.7-45.6) months. Median tumor diameter was 2.5 cm, and 17% of the tumors were sessile or flat. Most patients (83%) had no lymph node metastases. There was no association between tumor size and colonoscopy interval or lymph node status. Most patients (65%) had no adenomas during previous colonoscopy. Two patients (2.8%) eventually died from metastatic CRC. CONCLUSION: The high frequency of incident CRC in LS likely results from several factors. Our findings lend support to the hypothesis of fast conversion of adenomas to CRC, as 65% of patients had no report of polyps during previous colonoscopy. High-quality colonoscopies are essential, especially as tumors and adenomas are difficult to detect because of their frequent non-polypoid appearance. Early detection due to surveillance as well as the indolent growth of CRC, as demonstrated by the lack of lymph node metastases, contributes to the excellent survival observed.
BACKGROUND AND OBJECTIVE: Despite intensive colonoscopic surveillance, a substantial proportion of Lynch syndrome (LS) patients develop colorectal cancer (CRC). The aim of this study was to characterize incident CRC in LS patients. METHODS: All patients diagnosed with incident CRC after start of colonoscopic surveillance were identified in the Dutch LS Registry of 905 patients. A retrospective analysis of patient records was carried out for patient characteristics, survival, CRC characteristics and findings of previous colonoscopy. RESULTS: Seventy-one patients (7.8%) were diagnosed with incident CRC. Median interval between incident CRC diagnosis and previous colonoscopy was 23.8 (range 6.7-45.6) months. Median tumor diameter was 2.5 cm, and 17% of the tumors were sessile or flat. Most patients (83%) had no lymph node metastases. There was no association between tumor size and colonoscopy interval or lymph node status. Most patients (65%) had no adenomas during previous colonoscopy. Two patients (2.8%) eventually died from metastatic CRC. CONCLUSION: The high frequency of incident CRC in LS likely results from several factors. Our findings lend support to the hypothesis of fast conversion of adenomas to CRC, as 65% of patients had no report of polyps during previous colonoscopy. High-quality colonoscopies are essential, especially as tumors and adenomas are difficult to detect because of their frequent non-polypoid appearance. Early detection due to surveillance as well as the indolent growth of CRC, as demonstrated by the lack of lymph node metastases, contributes to the excellent survival observed.
Authors: Jurjen J Boonstra; Wouter H de Vos Tot Nederveen Cappel; Alexandra M J Langers; Hedwig van der Sluis; James H Hardwick; Hans F A Vasen Journal: Fam Cancer Date: 2017-04 Impact factor: 2.375
Authors: Jasper L A Vleugels; Husna Sahin; Yark Hazewinkel; Lianne Koens; Jose G van den Berg; Monique E van Leerdam; Evelien Dekker Journal: Gastrointest Endosc Date: 2017-12-09 Impact factor: 9.427
Authors: Hans F A Vasen; Mohamed Abdirahman; Richard Brohet; Alexandra M J Langers; Jan H Kleibeuker; Mariette van Kouwen; Jan Jacob Koornstra; Henk Boot; Annemieke Cats; Evelien Dekker; Silvia Sanduleanu; Jan-Werner Poley; James C H Hardwick; Wouter H de Vos Tot Nederveen Cappel; Andrea E van der Meulen-de Jong; T Gie Tan; Maarten A J M Jacobs; Faig Lall A Mohamed; Sijbrand Y de Boer; Paul C van de Meeberg; Marie-Louise Verhulst; Jan M Salemans; Nico van Bentem; B Dik Westerveld; Juda Vecht; Fokko M Nagengast Journal: Gastroenterology Date: 2010-03-02 Impact factor: 22.682
Authors: Edwin J Lai; Audrey H Calderwood; Gheorghe Doros; Oren K Fix; Brian C Jacobson Journal: Gastrointest Endosc Date: 2009-01-10 Impact factor: 9.427
Authors: Andrea E De Jong; Hans Morreau; Marjo Van Puijenbroek; Paul H c Eilers; Juul Wijnen; Fokko M Nagengast; Gerrit Griffioen; Annemieke Cats; Fred H Menko; Jan H Kleibeuker; Hans F A Vasen Journal: Gastroenterology Date: 2004-01 Impact factor: 22.682
Authors: Hans F A Vasen; Ignacio Blanco; Katja Aktan-Collan; Jessica P Gopie; Angel Alonso; Stefan Aretz; Inge Bernstein; Lucio Bertario; John Burn; Gabriel Capella; Chrystelle Colas; Christoph Engel; Ian M Frayling; Maurizio Genuardi; Karl Heinimann; Frederik J Hes; Shirley V Hodgson; John A Karagiannis; Fiona Lalloo; Annika Lindblom; Jukka-Pekka Mecklin; Pal Møller; Torben Myrhoj; Fokko M Nagengast; Yann Parc; Maurizio Ponz de Leon; Laura Renkonen-Sinisalo; Julian R Sampson; Astrid Stormorken; Rolf H Sijmons; Sabine Tejpar; Huw J W Thomas; Nils Rahner; Juul T Wijnen; Heikki Juhani Järvinen; Gabriela Möslein Journal: Gut Date: 2013-02-13 Impact factor: 23.059
Authors: Alexandra M J Langers; Jurjen J Boonstra; James C H Hardwick; Jolein van der Kraan; Arantza Farina Sarasqueta; Hans F A Vasen Journal: Fam Cancer Date: 2019-07 Impact factor: 2.375